Search for: "Neal Davis Editor"
Results 1 - 18
of 18
Sorted by Relevance
|
Sort by Date
21 Jul 2020, 9:11 am
The post Johnny Depp Accuser ‘Twisted’ Assault Tale, Witness Says appeared first on Neal Davis Blog. [read post]
7 Mar 2020, 10:01 am
appeared first on Neal Davis Blog. [read post]
16 Apr 2022, 6:01 am
Potischman, Edmund Polubinski, and Micayla Hardisty, Davis Polk & Wardwell LLP, on Saturday, April 16, 2022 Editor's Note: Neal A. [read post]
16 Apr 2022, 6:01 am
Potischman, Edmund Polubinski, and Micayla Hardisty, Davis Polk & Wardwell LLP, on Saturday, April 16, 2022 Editor's Note: Neal A. [read post]
7 May 2018, 6:03 am
Potischman, Davis Polk & Wardwell LLP, on Monday, May 7, 2018 Editor's Note: Andrew Ditchfield and Neal A. [read post]
4 Jun 2020, 11:52 am
Meaningful Action may look like:• Vote in local and federal elections• Civic Engagement: Sign Petitions, Contact Local Politicians, Letters to the Editor• Educate yourself on anti-racism• Elevate the experiences of marginalized and underrepresented voices• Donate to local and national fundraisers and organizations• Discuss racism with family, friends, neighbors, and community• Step in and be an active **upstander to interrupt and stop… [read post]
3 Jun 2016, 6:19 am
Posted by HLS Forum on Corporate Governance and Financial Regulation, on Friday, June 3, 2016 Editor's Note: This roundup contains a collection of the posts published on the Forum during the week of May 27–June 2, 2016. [read post]
11 May 2018, 6:01 am
Posted by Andrew Ditchfield and Neal A. [read post]
12 Apr 2019, 6:20 am
Posted by , on Friday, April 12, 2019 Editor's Note: This roundup contains a collection of the posts published on the Forum during the week of April 5–11, 2019. [read post]
22 Apr 2022, 5:33 am
Posted by the Harvard Law School Forum on Corporate Governance, on Friday, April 22, 2022 Editor's Note: This roundup contains a collection of the posts published on the Forum during the week of April 15-21, 2022. [read post]
22 Apr 2022, 5:33 am
Posted by the Harvard Law School Forum on Corporate Governance, on Friday, April 22, 2022 Editor's Note: This roundup contains a collection of the posts published on the Forum during the week of April 15-21, 2022. [read post]
16 Jan 2007, 4:04 am
.
Antitrust Trade and PracticeThursday, January 11, 2007By Neal R. [read post]
5 Aug 2013, 11:31 am
.; Kevin Brady (Chair, Subcommittee on Health); Sam Johnson; Devin Nunes; David Reichert (Chair, Subcommittee on Human Resources); Patrick “Pat” Tiberi; Xavier Becerra; Diane Black Earl Blumenauer; Vern Buchanan; Joseph Crowley; Danny Davis; Lloyd Doggett; Jim Gerlach; Tim Griffin; Lynn Jenkins; Mike Kelly; Ron Kind; John Larson; John Lewis; Kenny Marchant; Jim McDermott; Richard Neal; Bill Pascrell Jr.; Erik Paulsen; Tom Price; Charles Rangel; Tom… [read post]
12 Mar 2012, 8:13 am
In December 1833, the American Monthly Review commented on a newly published book by Joseph Story. [read post]
18 Jun 2010, 3:58 am
Making an Effective Case Directly to the TV Networks Jennifer Santos, Vice President, Ad Standards, NBC History of network challenges: 1971, FTC started encouraging comparative advertising. [read post]
6 Dec 2019, 3:00 am
Hunter Enters Plea in Federal Campaign Finance Case, Telling Judge, ‘Guilty’ San Diego Union-Tribune – Morgan Cook, Kristina Davis, and Jeff McDonald | Published: 12/3/2019 U.S. [read post]
13 Apr 2022, 6:23 am
Sponsor: Michael Burgess (R-TX) Cosponsors (38 Republicans): Marcy Kaptur (D-OH) Nicole Malliotakis (R-NY) Andre Carson (D-IN) Mike Quigley (D-IL) Andy Harris (R-MD) David McKinley (R-WV) Bill Johnson (R-OH) Steve Cohen (D-TN) Brian Fitzpatrick (R-PA) William Timmons (R-SC) Chris Pappas (D-NH) Fred Upton (R-MI) Mo Brooks (R-AL) Dan Crenshaw (R-TX) Eric Swalwell (D-CA) Ann Kuster (D-NH) Earl “Buddy” Carter (R-GA) Mike Johnson (R-LA) Gregory Steube (R-FL) Jim Costa (D-CA) Rodney… [read post]
13 Apr 2024, 3:33 pm
The results of one study by Hershel Jick and colleagues, presented as a letter to the editor, reported a relative risk of 0.58, with a 95% exact confidence interval, 0.03 – 2.9.[2] A year later, two researches, reporting a study based upon Medicaid databases, found no significant associations with PPA.[3] The FDA, however, did not approve a final monograph for PPA, with recognition of its “safe and effective” status because of occasional reports of hemorrhagic stroke that… [read post]
